Perrigo Price to Book Ratio 2010-2025 | PRGO
Historical price to book ratio values for Perrigo (PRGO) over the last 10 years. The current price to book ratio for Perrigo as of June 24, 2025 is 0.83.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Perrigo Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-24 | 26.75 | 0.84 | |
| 2025-03-31 | 27.74 | $31.81 | 0.87 |
| 2024-12-31 | 25.18 | $31.64 | 0.80 |
| 2024-09-30 | 25.44 | $33.45 | 0.76 |
| 2024-06-30 | 24.67 | $33.32 | 0.74 |
| 2024-03-31 | 30.62 | $34.39 | 0.89 |
| 2023-12-31 | 30.31 | $35.19 | 0.86 |
| 2023-09-30 | 29.82 | $34.97 | 0.85 |
| 2023-06-30 | 31.44 | $35.81 | 0.88 |
| 2023-03-31 | 32.94 | $35.73 | 0.92 |
| 2022-12-31 | 31.07 | $35.95 | 0.86 |
| 2022-09-30 | 32.24 | $34.20 | 0.94 |
| 2022-06-30 | 36.43 | $36.03 | 1.01 |
| 2022-03-31 | 34.28 | $37.92 | 0.90 |
| 2021-12-31 | 34.44 | $38.50 | 0.89 |
| 2021-09-30 | 41.63 | $38.76 | 1.07 |
| 2021-06-30 | 40.09 | $41.25 | 0.97 |
| 2021-03-31 | 35.20 | $41.63 | 0.85 |
| 2020-12-31 | 38.68 | $42.49 | 0.91 |
| 2020-09-30 | 39.52 | $42.64 | 0.93 |
| 2020-06-30 | 47.37 | $43.30 | 1.09 |
| 2020-03-31 | 41.05 | $42.46 | 0.97 |
| 2019-12-31 | 43.94 | $42.65 | 1.03 |
| 2019-09-30 | 47.34 | $42.32 | 1.12 |
| 2019-06-30 | 40.15 | $42.11 | 0.95 |
| 2019-03-31 | 40.42 | $41.92 | 0.96 |
| 2018-12-31 | 32.39 | $41.71 | 0.78 |
| 2018-09-30 | 59.00 | $41.65 | 1.42 |
| 2018-06-30 | 60.60 | $42.86 | 1.41 |
| 2018-03-31 | 69.10 | $44.42 | 1.56 |
| 2017-12-31 | 72.10 | $43.83 | 1.65 |
| 2017-09-30 | 69.90 | $42.91 | 1.63 |
| 2017-06-30 | 62.23 | $42.65 | 1.46 |
| 2017-03-31 | 54.59 | $42.31 | 1.29 |
| 2016-12-31 | 68.29 | $41.55 | 1.64 |
| 2016-09-30 | 75.63 | $52.18 | 1.45 |
| 2016-06-30 | 74.15 | $63.19 | 1.17 |
| 2016-03-31 | 104.47 | $67.91 | 1.54 |
| 2015-12-31 | 118.03 | $70.63 | 1.67 |
| 2015-09-30 | 128.17 | $73.31 | 1.75 |
| 2015-06-30 | 150.52 | 0.00 | |
| 2015-03-31 | 134.74 | $68.08 | 1.98 |
| 2014-12-31 | 135.94 | $69.00 | 1.97 |
| 2014-09-30 | 122.05 | $65.10 | 1.87 |
| 2014-06-30 | 118.37 | 0.00 | |
| 2014-03-31 | 125.50 | $63.97 | 1.96 |
| 2013-12-31 | 124.45 | $63.56 | 1.96 |
| 2013-09-30 | 99.99 | $26.19 | 3.82 |
| 2013-06-30 | 97.98 | 0.00 | |
| 2013-03-31 | 96.08 | $23.67 | 4.06 |
| 2012-12-31 | 84.11 | $22.44 | 3.75 |
| 2012-09-30 | 93.84 | $20.95 | 4.48 |
| 2012-06-30 | 95.20 | 0.00 | |
| 2012-03-31 | 83.33 | $18.98 | 4.39 |
| 2011-12-31 | 78.42 | $17.48 | 4.49 |
| 2011-09-30 | 78.20 | $16.57 | 4.72 |
| 2011-06-30 | 70.70 | 0.00 | |
| 2011-03-31 | 63.93 | $15.38 | 4.16 |
| 2010-12-31 | 50.87 | $14.17 | 3.59 |
| 2010-09-30 | 51.52 | $13.07 | 3.94 |
| 2010-06-30 | 47.34 | 0.00 | |
| 2010-03-31 | 47.01 | $11.57 | 4.06 |
| 2009-12-31 | 31.84 | $10.85 | 2.93 |
| 2009-09-30 | 27.13 | $10.50 | 2.59 |
| 2009-06-30 | 22.13 | 0.00 | |
| 2009-03-31 | 19.74 | $9.13 | 2.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.636B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.851B | 27.88 |
| Boston Scientific (BSX) | United States | $151.436B | 37.91 |
| Stryker (SYK) | United States | $144.721B | 30.26 |
| EssilorLuxottica (ESLOY) | France | $129.653B | 0.00 |
| Medtronic (MDT) | Ireland | $110.247B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.183B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.320B | 28.03 |
| Agilent Technologies (A) | United States | $32.988B | 21.51 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Terumo (TRUMY) | Japan | $26.976B | 35.04 |
| Koninklijke Philips (PHG) | Netherlands | $21.839B | 15.32 |
| Insulet (PODD) | United States | $21.652B | 84.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.103B | 11.63 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.776B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.410B | 22.31 |
| Lantheus Holdings (LNTH) | United States | $5.591B | 14.10 |
| Prestige Consumer Healthcare (PBH) | United States | $4.170B | 18.63 |
| Haemonetics (HAE) | United States | $3.462B | 15.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.203B | 26.62 |
| ICU Medical (ICUI) | United States | $3.152B | 23.24 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.11 |
| QuidelOrtho (QDEL) | United States | $1.870B | 12.86 |
| AtriCure (ATRC) | United States | $1.579B | 0.00 |
| Acuren (TIC) | United States | $1.283B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.120B | 11.37 |
| Neogen (NEOG) | United States | $1.035B | 13.25 |
| Green Thumb Industries (GTBIF) | United States | $1.018B | 22.91 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.853B | 8.59 |
| Kestra Medical Technologies (KMTS) | United States | $0.822B | 0.00 |
| CeriBell (CBLL) | United States | $0.668B | 0.00 |
| Evolus (EOLS) | United States | $0.605B | 0.00 |
| Owens & Minor (OMI) | United States | $0.562B | 4.67 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.537B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.514B | 0.00 |
| Valneva SE (VALN) | France | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.363B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Quanterix (QTRX) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.95 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.222B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.17 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.45 |
| TriSalus Life Sciences (TLSI) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.52 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.02 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.079B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 61.29 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.03 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |